[1] 刘深基,陈松森. 降钙素/降钙素基因相关肽基因前体RNA 的加工[J]. 国外医学:分子生物学分册,1999,21 (4): 196-200. [2] 彭玉华,拉莱·苏祖克,周 康,等. 子宫颈癌4 505例临床分析[J]. 中华妇产科杂志,2003,38 (12):764-765. [3] Magana J,Gomez R,Cisneros B,et al. Association of the CT gene (CA) polylmorphism with BMD in osteoporotic mexican women[J]. Clin Genet,2006,70 (5):402-408. [4] Buervenich S,Xiang F,Sydow J,et al. Identification of four novel polymorphisms in the calcitonin/alpha-CGRP(CALCA) gene and aninvestigation of their possible associations with Parkinson disease,schizophrenia,and manic depression[J]. Hum Mutat,2001,17 (5):435-436. [5] Widschwenter A,Muller HM,Fiegl H,et al. DNA methylation in serum and tumors of cervical cancer pationtes[J]. Clin Cancer Res,2004,10(2):565-571. [6] Wisman G,Nijhuis E,Hoque M,et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia[J]. Int J Cancer,2006,119 (8):1908-1914. [7] 盛 磊,阿仙姑·哈斯木,刘开江. 维吾尔族妇女宫颈病变病理进程与降钙素相关肽a表达的关系[J]. 癌变·畸变·突变,2011,23 (4):287-290. [8] 拉 莱,苏祖克,彭玉华,周 康,等. 新疆不同民族宫颈癌发病趋势分析[J]. 新疆大学学报,2006,29 (7):569-571. [9] Bouvard V,Baan R,Straif K,et al. A review of human carcinogens-part B:biological agents[J]. Lancet Oncol,2009, 10 (4):321-322. [10] de Sanjose S,Quint WG,Alemany L,et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J]. Lancet Oncol, 2010,11 (11):1048-1056. [11] 乔玉环,张梦真,史忘蓉. 子宫颈癌及其癌前病变组织端粒酶活性的研究[J]. 中华妇产科杂志,2001,36(8):483. [12] 萨姆布鲁克. 分子克隆实验指南[M]. 3版. 北京:科学出版社, 2002:1428-1430. [13] Tippins JR. CGRP:a novel neuropeptide from the calcitonin gene is the most potent vasodilator known[J]. J Hypertens, 1986,4(5 Sup 1):102-105. [14] Lambert RW,Granstein RD. Neuropeptides and Langerhans cells [J]. Exp Dermatol,1998,7(2/3):73–80. [15] Misery L. Skin,immunity and the nervous system[J]. Br J Dermatol,1997,137(6):843–850. [16] Shuiying H,Marge E,Ralph PT,et al. Detection of serum deoxyribonucleic acid methylation markers:a novel diagnostic tool for thyroid cancer[J]. Clin Endocrinol Metab,2006,91 (1):98-104. [17] 张翠娟,周庚寅. DNA甲基化和组蛋白修饰在肿瘤中的作用[J]. 中国现代普通外科进展,2004,7 (2):333-336. [18] 曹云飞,陈利生. 结直肠癌中DNA甲基化的研究进展[J]. 中华消化外科杂志,2006,5 (5):380-382. [19] Andreas W,Hannes MM,Heidi F,et al. DNA methylation in serum and tumors of cervical cancer patients[J]. Clin Cancer Res,2004,15,10 (2):565-571. [20] Jaenisch R,Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals[J]. Nat Rev Genet,2003,33 (3):245-254. [21] Koopman LA,Corver WE,van der Slik AR,et al. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer[J]. J Exp Med,2000,191 (3):961–976. [22] Chil A,Sikorski M,Bobek M,et al. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix[J]. Acta Obstet Gynecol Scand, 2003,82:1146–1152. [23] Mehta A,Jordanova E,Kenter G,et al. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma[J]. Cancer Immunol Immunother,2008,57 (2):197-206. [24] 胡丹妮,李 锋,杨安强. SFRP1 基因启动子区甲基化与宫颈癌及癌前病变的相关性研究[J]. 石河子大学学报,2010, 6 (3):326-328. [25] Nafeisha K,Hui H,Abida A,et al. The association of altered RARβ expression with the cervical lesion pathogenesis[J]. Chinese-German J Clin Oncol,2011,10 (9): 526-530. [26] 贺 慧,阿比达·阿不都卡德尔,纳菲沙·卡德尔,等. 维、汉族妇女宫颈病变进程与雌激素受体1(ESR1)蛋白表达缺失的关系及意义[J]. 科技导报,2010,28(7):32-36. |